Combination therapy is arguably the norm in acne care, but what do we know about the concomitant use of newer topical treatments? AARS Treasurer Emmy Graber, MD discusses findings from her recent study. The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidradenitis suppurativa, and rosacea. Support AARS …

This special edition of the AARS Hot Topics Podcast features updates from Howa Yeung, MD, Lauren Kole, MD, Hilary Baldwin, MD, and Benjamin Ungar, MD, speaking from the Annual Meeting of the American Academy of Dermatology. They offer updates on safe use of antibiotics, emerging strategies for patient care, and the influence of diet in acne and ros…

There are energy-based devices approved for the treatment of acne plus others with promising data. But there is some confusion about what works and what doesn't. AARS Treasurer Emmy Graber, MD provides an overview of findings from a recent study. The American Acne and Rosacea Society (AARS) is the only professional society focused on acne, hidraden…

Approved late last year to treat HS, bimekizumab was the subject of several publications in 2024, including phase 3 pivotal trial data. AARS President James Q. Del Rosso, DO gives an update on key data considerations. You can watch Dr. Del Rosso's full discussion of trial design, efficacy data, and safety findings online at acneandrosacea.org. The …

With a recent publication assessing the frequency of lab monitoring for patients with acne being treated with isotretinoin, AARS President Elect Jonathan Weiss, MD, FAAD, weighs in on the latest expert thinking. He also compares the current publication to the Guidelines of Care for Acne from the American Academy of Dermatology. The American Acne an…

New research offers new insights on the use of cannabis among patients with hidradenitis suppurativa. The findings don't surprise Adam Friedman, MD, Professor and Chair of Dermatology and Director of the HS program at GW School of Medicine and Health Sciences. He shares his insights on the paper, published in the Journal of Cutaneous Medicine and S…

In a new AARS video dermatologist Andrea Zaenglein, MD, FAAD and OB/Gyn Sarah K. Horvath, MD, MSHP, FACOG discuss patient counseling and recommendations for prescribing emergency contraception for patients on isotretinoin. Crown Laboratories, which owns the PanOxyl line of acne care products, plans to acquire Revance Therapeutics. New data for izok…

As part of its ongoing efforts to support research and share scientific knowledge about acne, hidradenitis suppurativa (HS), and rosacea, the American Acne and Rosacea Society (AARS) hosted its 11th Annual Scientific Symposium on May 15, 2024. The AARS was thrilled to welcome the attendees of the annual Society for Investigative Dermatology meeting…

Dr. Andrea Zaenglein was recognized at the 17th Annual AARS Networking Reception in San Diego last month, as she concluded her term as AARS President. Incoming President Dr. Jim Del Rosso. Other new officers and Directors have been announced. AARS leadership past and present was well represented from the podium at the Annual Meeting of the American…